Pharmaceutical Business review

Mylan appoints new chief compliance officer

Ms Lacerca has experience in multi-jurisdictional corporate compliance, international business transactions, pharmaceutical industry regulation, corporate policy and international environmental law.

She joins Mylan from Bristol-Meyers Squibb where she was director of compliance for Latin America, Canada and Puerto Rico. While there, she was responsible for all compliance-related matters in the regions. Prior to Bristol-Meyers Squibb, Ms Lacerca held executive and senior counsel positions with Merck & Co., Microsoft and AT&T.

Mylan vice chairman and CEO, Robert Coury, said: “As we transition to become a global leader in our industry we are committed to maintaining a culture of integrity and quality across all lines of our business. It is our pleasure to welcome Fabiana to Mylan. Fabiana’s extensive experience counseling companies in the pharmaceutical industry with operations in multiple countries will be invaluable to Mylan’s operations around the world.”